Orifarm gains OTC business through Takeda deal

24 April 2020 - Deborah Wilkes

Danish pharmaceutical company Orifarm is acquiring a portfolio of OTC and prescription pharmaceuticals sold in Europe from Japan’s Takeda in a deal worth up to approximately USD670 million.